CD38, BCL-2, PD-1, and PD-1L expression in nodal peripheral T-cell lymphoma: Possible biomarkers for novel targeted therapies?-Reference-Cited by-同舟云学术

CD38, BCL-2, PD-1, and PD-1L expression in nodal peripheral T-cell lymphoma: Possible biomarkers for novel targeted therapies?

Published:2016-11-10 Issue:1 Volume:92 Page:E1-E2
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Zaja Francesco¹,Tabanelli Valentina²,Agostinelli Claudio³⁴,Calleri Angelica²,Chiappella Annalisa⁵,Varettoni Marzia⁶,Zinzani Pier Luigi⁷,Volpetti Stefano¹,Sabattini Elena³,Fanin Renato¹,Pileri Stefano A.²⁴

Affiliation:

1. Clinica Ematologica, DISM, Azienda Sanitaria Universitaria Integrata; Udine Italy

2. Unit of Haematopathology, European Institute of Oncology; Milan Italy

3. Unità di Emolinfopatologia, Dipartimento di Ematologia & Oncologia Azienda Ospedaliero - Universitaria; Bologna Italy

4. Department of Experimental; Diagnostic and Specialty Medicine, Bologna University School of Medicine; Bologna Italy

5. S.C. Ematologia A.O.U. Città della Salute e della Scienza; Torino Italy

6. Dipartimento di Ematologia e Oncologia; Fondazione IRCCS Policlinico San Matteo; Pavia Italy

7. Institute of Hematology “L. e A. Seràgnoli”, University of Bologna; Bologna Italy

Funder

Italian Association for Cancer Research

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.24571/fullpdf

Reference6 articles.

1. The 2016 revision of the World Health Organization (WHO) classification of lymphoid neoplasms;Swerdlow;Blood,2016

2. Immunohistochemistry as a valuable tool to assess CD30 expression in peripheral T-cell lymphomas: High correlation with mRNA levels;Bossard;Blood,2014

3. Differential expression of BCL-2 family proteins in ALK-positive and ALK-negative anaplastic large cell lymphoma of T/null-cell lineage;Rassidakis;Am J Pathol,2001

4. BCL-2 family proteins in peripheral T-cell lymphomas: Correlation with tumour apoptosis and proliferation;Rassidakis;J Pathol,2003

5. Programmed death 1 is a marker of angioimmunoblastic T-cell lymphoma and B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia;Xerri;Hum Pathol,2008

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Other Promising Cell Surface Receptors;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21

2. Preclinical evaluation of anti-CD38 therapy in mature T-cell neoplasms;Blood Advances;2023-07-17

3. Education and Empowering Special Forces to Eradicate Secret Defectors: Immune System-Based Treatment Approaches for Mature T- and NK-Cell Malignancies;Cancers;2023-04-28

4. Cellular and humoral immunotherapy in children, adolescents and young adults with non-Hodgkin lymphoma;Best Practice & Research Clinical Haematology;2023-03

5. Sensitivity of canine hematological cancers to BH3 mimetics;Journal of Veterinary Internal Medicine;2022-11-25